Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Pierconti

Showing results (21-30 of 112) with videos related to

Pageof 12
Sort By:
BMC Cancer|August 4, 2019
Urinary bladder leiomyosarcoma with osteoclast-like multinucleated giant cells: a case reportVincenzo Fiorentino, Francesco Pierconti, Niccolò Lenci, et al.
The Journal of Infection|June 21, 2006
Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomasMaurizio Martini, Daniela Capello, Diego Serraino, et al.
Clinical Genitourinary Cancer|July 25, 2022
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder CancerMauro Ragonese, Luca Di Gianfrancesco, Giuseppe Palermo, et al.
European Journal of Radiology|June 26, 2012
T2-weighted hypointense lesions within prostate gland: differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging--hystopatology correlationsAnna Lia Valentini, Benedetta Gui, Alessandro Cina, et al.
The Prostate|August 19, 2010
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behaviorFrancesco Pierconti, Maurizio Martini, Francesco Pinto, et al.
International Journal of Molecular Sciences|July 27, 2022
A Novel Morphological Parameter Predicting Fibrotic Evolution in Myeloproliferative Neoplasms: New Evidence and Molecular InsightsVincenzo Fiorentino, Pietro Tralongo, Maurizio Martini, et al.
Oncotarget|March 2, 2018
Monoinstitutional real world experience in management of Vinflunine as second line therapy for transitional cell carcinoma of the urotheliumGiovanni Schinzari, Ernesto Rossi, Francesco Pierconti, et al.
Frontiers in Endocrinology|October 2, 2019
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot StudyGiuseppe Grande, Domenico Milardi, Maurizio Martini, et al.
Urologia|August 7, 2012
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary resultsAlessandro Calarco, Francesco Pinto, Francesco Pierconti, et al.
Journal of Clinical Medicine|November 11, 2022
Purely Off-Clamp Partial Nephrectomy: Robotic Approach Better than Open Using a Pentafecta Outcome with Propensity Score MatchingCarlo Gandi, Angelo Totaro, Riccardo Bientinesi, et al.
Pageof 12

Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
BMC Cancer|August 4, 2019
Urinary bladder leiomyosarcoma with osteoclast-like multinucleated giant cells: a case reportVincenzo Fiorentino, Francesco Pierconti, Niccolò Lenci, et al.
The Journal of Infection|June 21, 2006
Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomasMaurizio Martini, Daniela Capello, Diego Serraino, et al.
Clinical Genitourinary Cancer|July 25, 2022
The Role of Bladder Epicheck Test In Follow-Up of Patients with Non-Muscle Invasive Bladder CancerMauro Ragonese, Luca Di Gianfrancesco, Giuseppe Palermo, et al.
European Journal of Radiology|June 26, 2012
T2-weighted hypointense lesions within prostate gland: differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging--hystopatology correlationsAnna Lia Valentini, Benedetta Gui, Alessandro Cina, et al.
The Prostate|August 19, 2010
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behaviorFrancesco Pierconti, Maurizio Martini, Francesco Pinto, et al.
International Journal of Molecular Sciences|July 27, 2022
A Novel Morphological Parameter Predicting Fibrotic Evolution in Myeloproliferative Neoplasms: New Evidence and Molecular InsightsVincenzo Fiorentino, Pietro Tralongo, Maurizio Martini, et al.
Oncotarget|March 2, 2018
Monoinstitutional real world experience in management of Vinflunine as second line therapy for transitional cell carcinoma of the urotheliumGiovanni Schinzari, Ernesto Rossi, Francesco Pierconti, et al.
Frontiers in Endocrinology|October 2, 2019
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot StudyGiuseppe Grande, Domenico Milardi, Maurizio Martini, et al.
Urologia|August 7, 2012
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary resultsAlessandro Calarco, Francesco Pinto, Francesco Pierconti, et al.
Journal of Clinical Medicine|November 11, 2022
Purely Off-Clamp Partial Nephrectomy: Robotic Approach Better than Open Using a Pentafecta Outcome with Propensity Score MatchingCarlo Gandi, Angelo Totaro, Riccardo Bientinesi, et al.
Pageof 12